As the newest addition to incretin-based drugs, tirzepatide harbors the potential to counteract most of the pathogenetic mechanisms underpinning CKD in T2D displaying unprecedented features in terms of glucose and weight lowering, accompanied by promotion of insulin sensitivity, control of SBP, dyslipidemia, and biomarkers of inflammation and endothelial dysfunction
With its beaded skin, lumbering gait, and tendency to hide out in the heat of the day, the Gila monster doesnt exactly scream medical breakthrough. But behind that prehistoric glare is a biological secret that changed how we treat type 2 diabetes and obesity
Some of the adverse events are serious and some patients reported seeking medical attention for their symptoms, including nausea, vomiting, diarrhea, abdominal pain and constipation
The product contains berberine and other botanical extracts, with no evidence of transdermal efficacy